Policy rebuttal. HIV vaccine trial justified.
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D017326:Clinical Trials, Phase III as Topic; D015483:HIV Antibodies / Q000096:biosynthesis / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007115:Immunization Schedule; D007117:Immunization, Secondary; D009316:National Institutes of Health (U.S.); D013785:Thailand; D014481:United States; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
D016915:AIDS Vaccines; D015483:HIV Antibodies; D014614:Vaccines, Synthetic
Biomedical and Behavioral Research